| | 2000 Annual report on the state of the drugs problem in the |
| | 0,38 | | MB | European Union |
| | 43 | | stron |
| | 4630 | | ID | European Monitoring Centre for Drugs and Drug Addiction |
| | 2000 | | rok |
| | Contents |
| | Preface 5 |
| | Acknowledgements 6 |
| | C H A P T E R 1 7 |
| | Overall trends 7 |
| | Trends in drug use and its consequences 7 |
| | Cannabis 7 |
| | Amphetamines and ecstasy 7 |
| | Cocaine 7 |
| | Heroin 8 |
| | Multiple drug use 8 |
| | Problem drug use and demand for treatment 8 |
| | Drug-related deaths 8 |
| | Drug-related infectious diseases 9 |
| | Other morbidity 9 |
| | Trends in responses to drug use 9 |
| | Policy and strategy developments 9 |
| | Prevention 9 |
| | Reducing the harmful consequences of drug use 10 |
| | Treatment 10 |
| | C H A P T E R 2 11 |
| | Prevalence and patterns of drug use 11 |
| | Prevalence of drug use 11 |
| | Drug use in the general population 11 |
| | Drug use in the school population 13 |
| | National estimates of problem drug use 14 |
| | Health consequences of drug use 15 |
| | Demand for treatment 15 |
| | Drug-related deaths 17 |
| | Mortality among drug users 19 |
| | Drug-related infectious diseases 19 |
| | Law-enforcement indicators 20 |
| | ‘Arrests’ for drug offences 21 |
| | Prison data 21 |
| | Drug-market indicators: seizures, price, purity 21 |
| | Cannabis 21 |
| | Heroin 21 |
| | Cocaine 22 |
| | Amphetamines, ecstasy and LSD 22 |
| | C H A P T E R 3 23 |
| | Responses to drug use 23 |
| | Policy and strategy developments 23 |
| | National drug policies 23 |
| | European Union Drugs Strategy (2000–04) 24 |
| | Quality assurance 25 |
| | Demand-reduction responses 25 |
| | Prevention 25 |
| | Reducing the harmful consequences of drug use 26 |
| | Treatment 27 |
| | C H A P T E R 4 29 |
| | Selected issues 29 |
| | Substitution treatment 29 |
| | Substitution substances 29 |
| | Introduction of substitution treatments in the EU 30 |
| | Extent and settings of substitution services 30 |
| | Prosecution of drug-related offences 31 |
| | Possession of heroin 31 |
| | Property offences 32 |
| | Selling drugs 32 |
| | Problems facing women drug users and their children 33 |
| | Drug use among women 33 |
| | Infectious diseases 33 |
| | Pregnancy and women with children 34 |
| | Drug treatment 34 |
| | Women-specific drug prevention 35 |
| | C H A P T E R 5 37 |
| | The drugs problem in central and eastern Europe 37 |
| | Prevalence and patterns of drug use 37 |
| | Cannabis 37 |
| | Opiates 38 |
| | Cocaine 39 |
| | Synthetic drugs 39 |
| | Other substances 40 |
| | Responses 40 |
| | Institutional and legislative responses 40 |
| | Demand and supply reduction 40 |
| | EMCDDA publications 2000 41 |
| | Reitox focal points 42 |